XBiotech (XBIT) Receivables (2020 - 2025)
XBiotech (XBIT) reported Receivables of $450,000 for Q3 2025, down 38.4% from $730,000 a year earlier and down 6.3% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Receivables (2020 - 2025) Analysis & Trends
At the end of FY2024, XBiotech posted Receivables of $700,000, down 18.6% from FY2023.
- Receivables has a four-year compound annual growth rate of -35.8% (FY2020 to FY2024).
- By year, Receivables came in at $860,000 in FY2023 (-29.3%), $1.22 million in FY2022 and $4.11 million in FY2020.
- The Q3 2025 figure ranks as the lowest quarterly Receivables since Q3 2021.
- Year over year, Receivables has now declined in each of the last five quarters, with an average decline of 32.2% over the last six quarters.
- Over the past five years, the year-over-year decline in Receivables ranged from 17.1% (Q3 2024) to 99.9% (Q2 2021).
- Per Business Quant data, the three quarters before Q3 2025 came in at $480,000 (Q2 2025), $480,000 (Q1 2025) and $700,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | XBiotech | 65.55 Mn | 65.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 450,000.00 |
| Jun 30, 2025 | 480,000.00 |
| Mar 31, 2025 | 480,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 870,000.00 |
| Mar 31, 2024 | 870,000.00 |
| Dec 31, 2023 | 860,000.00 |
| Sep 30, 2023 | 881,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 500,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 1.69 Mn |
| Dec 31, 2020 | 4.11 Mn |
| Sep 30, 2020 | 6.06 Mn |
| Jun 30, 2020 | 20.68 Mn |
| Mar 31, 2020 | 9.68 Mn |
API Access
XBiotech Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();